Category Archives: cancer research
Former UAB natural products researcher up to a dozen retractions
A researcher who studied natural products for cancer at the University of Alabama, Birmingham (UAB), had six papers retracted last month, bringing him to a total of 12. Four of the recently retracted papers by Santosh Katiyar had appeared in PLOS ONE, and two had been published in Cancer Research. They have together been cited … Continue reading Former UAB natural products researcher up to a dozen retractions
Posted by in cancer research, PLOS One, united states
Former University of Maryland cancer researcher up to 21 retractions
Anil Jaiswal, who until a year ago was a cancer researcher at the University of Maryland, Baltimore, has had four more papers retracted. That makes 21 for Jaiswal, who joins our leaderboard of the 30 researchers with the most retractions. All four new retractions appear in journals published by the American Association for Cancer Research, … Continue reading Former University of Maryland cancer researcher up to 21 retractions
Posted by in anil jaiswal, cancer research, clinical cancer research
Researcher who once tried to sue critics has another dozen papers retracted
A cancer researcher who went to court — unsuccessfully — claiming that commenters on PubPeer had cost him a new job has just lost another 12 papers. The twelve now-retracted papers by Fazlul Sarkar and colleagues — as well as another by Sarkar that is now subject to an editor’s note — all appeared in … Continue reading Researcher who once tried to sue critics has another dozen papers retracted
Cancer journals retract 10 papers, flag 8 more, and apologize for the delay
Five journals published by a prominent cancer research society have retracted a total of 10 papers — most of them by a former researcher at the MD Anderson Cancer Center in Houston. Nine of the 10 retractions share that researcher, Bharat Aggarwal, as an author. Aggarwal — who more than five years ago threatened to sue … Continue reading Cancer journals retract 10 papers, flag 8 more, and apologize for the delay
Nearly two years after a university asked for retractions, two journals have done nothing
How long should a retraction take? That’s a complex question, of course, depending on how long the alleged issues with a paper take to be investigated, whether authors — and their lawyers — fight tooth-and-nail against a retraction, and other factors. But once a university officially requests a retraction, how long should one take? The … Continue reading Nearly two years after a university asked for retractions, two journals have done nothing
Posted by in American Association for Cancer Research, cancer research
Early data on potential anti-cancer compound now in human trials was falsified, company admits
A pharmaceutical company has admitted that one of its former researchers falsified early data on a compound that’s designed to fight cancer, now in human trials. The data, published as an abstract in August 2015 in the journal Cancer Research, reported a therapeutic benefit of acalabrutinib in a mouse model of pancreatic cancer. The compound, […]
The post Early data on potential anti-cancer compound now in human trials was falsified, company admits appeared first on Retraction Watch.
Drip, drip: UCLA investigation finds more image duplications
Image duplications and unsupported data continue to plague a network of cancer researchers that includes the former vice chancellor for research at the University of California, Los Angeles, James Economou. On July 2, the editors at Cancer Research retracted a 2011 paper that Economou published as last author, saying it suffered from image duplication and […]
The post Drip, drip: UCLA investigation finds more image duplications appeared first on Retraction Watch.
A university asked for numerous retractions. Eight months later, three journals have done nothing.
When journals learn papers are problematic, how long does it take them to act? We recently had a chance to find out as part of our continuing coverage of the case of Anil Jaiswal at the University of Maryland, who’s retracted 15 papers (including two new ones we recently identified), and has transitioned out of […]
The post A university asked for numerous retractions. Eight months later, three journals have done nothing. appeared first on Retraction Watch.
Posted by in American Association for Cancer Research, biochem biophys research comm, cancer biology, cancer research, Chemico-Bio Interactions, clinical cancer research, company of biologists, duplication retractions, elsevier, FEBS J, free radical biology medicine, freely available, image manipulation, jbc retractions, journal of cell science, misconduct investigations, molecular cancer therapeutics, nature publishing group, oncogene (journal), society journal retractions, united states, wiley, wiley retractions
Cancer researcher earns 3 more retractions following NIH misconduct investigation
A researcher formerly based at the National Cancer Institute has earned three new retractions following an investigation that found she committed misconduct. In May of last year, Stephanie Watkins, who now works at Loyola Medicine, earned two retractions, which mention a review by an investigation committee at the National Institutes of Health. Two of the new notes, published in Cancer […]
The post Cancer researcher earns 3 more retractions following NIH misconduct investigation appeared first on Retraction Watch.
Cancer Research retraction is fifth for Robert Weinberg; fourth for his former student
Another domino has fallen in a chain of retractions for Robert Weinberg, the man who discovered the first tumor-causing gene in humans, along with the first tumor suppressor gene: Cancer Research just retracted a paper of his on some of the molecular steps to metastasis. The paper, “Concurrent Suppression of Integrin α5, Radixin, and RhoA Phenocopies […]
The post Cancer Research retraction is fifth for Robert Weinberg; fourth for his former student appeared first on Retraction Watch.